New findings on inhibitor development: from registries to clinical studies von Peyvandi, F., Ettingshausen, C. E., Goudemand, J., Jiménez‐Yuste, V., Santagostino, E., Makris, M.

Volltext

Symptomatic Onset of Severe Hemophilia A in Childhood is Dependent on the Presence of Prothrombotic Risk Factors von Escuriola Ettingshausen, C., Halimeh, S., Kurnik, K., Schobess, R., Wermes, C., Junker, R., Kreuz, W., Pollmann, H., Nowak-Göttl, U.

Volltext

Replacement Therapy with Protein C Concentrate in Infants and Adolescents with Meningococcal Sepsis and Purpura Fulminans von Ettingshausen, Carmen Escuriola, Veldmann, Alex, Beeg, Thomas, Schneider, Wilfred, Jäger, Gudrun, Kreuz, Wolfhart

Volltext

Effects of the factor V G1691A mutation and the factor II G20210A variant on the clinical expression of severe hemophilia A in children results of a multicenter study von Kurnik, Karin, Kreuz, Wolfhart, Horneff, Sylvia, During, Christine, Schobess, Rosemarie, Bidlingmaier, Christoph, Ettingshausen, Carmen Escuriola, Krumpel, Anne, Bogdanova, Nadia, Nowak-Gottl, Ulrike

Volltext

Neonatal Sepsis: A Challenge in Hemostaseology von Kreuz, Wolfhart, Veldmann, Alex, Fischer, Doris, Schlösser, Rolf, Volk, Werner Rettwitz, Ettingshausen, Carmen Escuriola

Volltext

Role of von Willebrand factor in immune tolerance induction von Ettingshausen, Carmen Escuriola, Kreuz, Wolfhart

Volltext

Portal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of F VIII after intramural jejunal bleeding--successful thrombolysi... von Ettingshausen, C E, Saguer, I M, Kreuz, W

Volltext

Epidemiology of inhibitors and current treatment strategies von Kreuz, W, Ettingshausen, CE, Auerswald, G, Saguer, IM, Becker, S, Funk, M, Heller, C, Klarmann, D, Klingebiel, T, GTH PUP Study Group

Volltext

Combined Heterozygous Factor XIII-Deficiency in a Family Case Report von Rusicke, E., Ivaskevicius, V., Klarmann, D., Escuriola Ettingshausen, C., Oldenburg, J., Kreuz, W.

Volltext

Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement von Iorio, A., Iserman, E., Blanchette, V., Dolan, G., Escuriola Ettingshausen, C., Hermans, C., Negrier, C., Oldenburg, J., Reininger, A., Rodriguez‐Merchan, C., Spannagl, M., Valentino, L. A., Young, G., Steinitz‐Trost, K. N., Gringeri, A.

Volltext

Administration of Recombinant Factor FVIIa (NovoSeven, NovoNordisk) in a Patient with Glanzmann Thrombasthenia von Zyschka, A., Elanjikal, Z., Escuriola Ettingshausen, C., Martinez Saguer, I., Linde, R., Kreuz, W.

Volltext

Prophylaxis re‐visited: The potential impact of novel factor and non‐factor therapies on prophylaxis von Carcao, M., Lambert, T., Leissinger, C., Escuriola‐Ettingshausen, C., Santagostino, E., Aledort, L.

Volltext

First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune to... von Kreuz, W., Escuriola Ettingshausen, C., Vdovin, V., Zozulya, N., Plyushch, O., Svirin, P., Andreeva, T., Bubanská, E., Campos, M., Benedik-Dolničar, M., Jiménez-Yuste, V., Kitanovski, L., Klukowska, A., Momot, A., Osmulskaya, N., Prieto, M., Šalek, S. Z., Velasco, F., Pavlova, A., Oldenburg, J., Knaub, S., Jansen, M., Belyanskaya, L., Walter, O.

Volltext

Inhibitor development and mortality in non‐severe hemophilia A von Eckhardt, C. L., Loomans, J. I., Velzen, A. S., Peters, M., Mauser‐Bunschoten, E. P., Schwaab, R., Mazzucconi, M. G., Tagliaferri, A., Siegmund, B., Reitter‐Pfoertner, S. E., Bom, J. G., Fijnvandraat, K., Fijnvandraat, K., Peters, M., Kamphuisen, P. W., Kamphuisen, P. W., Bom, J. G., Peerlinck, K., Oldenburg, J., Santagostino, E., Astermark, J., Eckhardt, C.L, Velzen, A.S, Streefkerk, N., Loomans, J. L., Eijkelenburg, A., Jansen, A. J., Kruijt, C. C., Tienoven, B., Baar, A. C. G., Corten, I. W., Meijer, K., Nijziel, M. R., Dors, N., Hamulyak, K., Beckers, E., Brons, P. P., Laros‐van Gorkom, B. A. P., Heerde, W. L., Leebeek, F., Kruip, M., Cnossen, M. H., Mauser‐Bunschoten, E., Fischer, K., Smiers, F. J., Hermans, C., Schwaab, R., Siegmund, B., Klamroth, R., Escuriola‐Ettingshausen, C., Königs, C., Petrini, P., Holmström, M., Mäkipernaa, A., Male, C., Pabinger, I., Reitter‐Pfoertner, S. E., Keenan, R. D., Liesner, R., Khair, K., Yee, T. T., Hart, D. P., Rangarajan, S., Mitchell, M., Thompson, G., Haya, S., Moret, A., Cid, A. R., Jimenez‐Yuste, V., Mancuso, M. E., Mazzuconni, M. G., Santoro, C., Morfini, M., Castaman, G., Schinco, P., Tagliaferri, A., Rivolta, G. F., Platokouki, H., McRae, S.

Volltext

Lanadelumab demonstrates rapid and sustained prevention of hereditary angioedema attacks von Riedl, Marc A., Maurer, Marcus, Bernstein, Jonathan A., Banerji, Aleena, Longhurst, Hilary J., Li, H. Henry, Lu, Peng, Hao, James, Juethner, Salomé, Lumry, William R., Hébert, J, Ritchie, B, Sussman, G, Yang, WH, Escuriola Ettingshausen, C, Magerl, M, Martinez‐Saguer, I, Maurer, M, Staubach, P, Zimmer, S, Cicardi, M, Perego, F, Wu, MA, Zanichelli, A, Al‐Ghazawi, A, Shennak, M, Zaragoza‐Urdaz, RH, Ghurye, R, Longhurst, HJ, Zinser, E, Anderson, J, Banerji, A, Baptist, AP, Bernstein, JA, Boggs, PB, Busse, PJ, Christiansen, S, Craig, T, Davis‐Lorton, M, Gierer, S, Gower, RG, Harris, D, Hong, DI, Jacobs, J, Johnston, DT, Levitch, ES, Li, HH, Lockey, RF, Lugar, P, Lumry, WR, Manning, ME, McNeil, DL, Melamed, I, Mostofi, T, Nickel, T, Otto, WR, Petrov, AA, Poarch, K, Radojicic, C, Rehman, SM, Riedl, MA, Schwartz, LB, Shapiro, R, Sher, E, Smith, AM, Smith, TD, Soteres, D, Tachdjian, R, Wedner, HJ, Weinstein, ME, Zafra, H, Zuraw, BL

Volltext

PB1245 Efficacy, Safety and Dosing of Pasteurized Plasma-Derived von Willebrand Factor/Factor VIII Concentrate for the Treatment of von Willebrand Disease: A Systematic Review von Escuriola-Ettingshausen, C., Lassila, R., Escolar, G., Male, C., Schirner, K., Heyder, L., Berntorp, E.

Volltext

The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitors von Velzen, Alice S. van, Eckhardt, Corien L., Streefkerk, Nina, Peters, Marjolein, Hart, Daniel P., Hamulyak, Karly, Klamroth, Robert, Meijer, Karina, Nijziel, Marten, Schinco, Piercarla, Yee, Thynn T., Bom, Johanna G. van der, Fijnvandraat, Karin

Volltext

Factor VIII Inhibitors in Patients with Hemophilia A: Epidemiology of Inhibitor Development and Induction of Immune Tolerance for Factor VIII von Kreuz, Wolfhart, Becker, Sabine, Lenz, Elisabeth, Martinez-Saguer, Inmaculada, Escuriola-Ettingshausen, Carmen, Funk, Markus, Ehrenforth, Silke, Auerswald, Günther, Kornhuber, Bernhard

Volltext

DE2931395 von SCHNEGELBERGER, HARALD. DR., 5653 LEICHLINGEN, DE, BEHR, NORBERT-VOLKSW., 5657 HAAN, DE, SIRTL, WOLFGANG, ZUERICH, CH, ETTINGSHAUSEN, OTHMAR VON. DR., 4000 DUESSELDORF, DE, MEI, HENK VAN DER, 3260 RINTELN, DE

Volltext bestellen